Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 2/20 | 0.32 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 3/20 | 0.31 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 2/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.30 |
| ▸ | ATM | Q13315 | 2/20 | 0.30 |
| ▸ | RECQL | P46063 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9529398 | 0.98 | CYP1A2 (0.44) | CYP1A2GAAALDH1A1TSHRALOX15 | |
| Methylene Chloride SCHEMBL28551225 | 0.93 | CYP1A2 (0.41) | CYP1A2GAAALDH1A1HTTPIK3CA | |
| SCHEMBL329417 | 0.84 | CYP1A2 (0.52) | CYP1A2GAAALDH1A1TSHRALOX15 | |
| SCHEMBL8795 | 0.84 | CYP1A2 (0.52) | CYP1A2GAAALDH1A1TSHRALOX15 | |
| SCHEMBL8844371 | 0.81 | GAA (0.47) | CYP1A2GAAALDH1A1TSHRHTT | |
| SCHEMBL1131131 | 0.81 | GAA (0.47) | CYP1A2GAAALDH1A1TSHRHTT | |
| SCHEMBL9433260 | 0.75 | POLB (0.40) | CYP1A2ALDH1A1TSHRMAPTSMN1; SMN2 | |
| SCHEMBL12393233 | 0.74 | TSHR (0.35) | TSHR | |
| SCHEMBL94294 | 0.74 | — | — | |
| SCHEMBL802854 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 103 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112694447-A | Synthesis method of N-methyl triazine | 营口昌成新材料科技有限公司 | 2021-04-23 | — | — | CN | claimed |
| US-11840545-B1 | Spirooxindole-copper complex as novel efficient anticorrosion agent for C-steel | King Faisal University (SA) | 2023-12-12 | — | — | US | disclosed |
| US-20230219983-A1 | TETRADENTATE DIAMINODIPHOSPHINE LIGAND AND TRANSITION METAL COMPLEX, AND METHOD FOR MANUFACTURING SAME AND APPLICATION FOR SAME | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2023-07-13 | — | — | US | disclosed |
| US-11639362-B2 | Tetradentate diaminodiphosphine ligand and transition metal complex, and method for manufacturing same and application for same | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2023-05-02 | — | — | US | disclosed |
| US-20220047724-A1 | NOVEL TRICARBOCYANINE-CYCLODEXTRIN(S) CONJUGATES AND USE THEREOF | CYANAGEN S R L (IT) | 2022-02-17 | — | — | US | disclosed |
| US-11179481-B2 | Tricarbocyanine-cyclodextrin(s) conjugates and use thereof | CYANAGEN S.R.L. (IT) | 2021-11-23 | — | — | US | disclosed |
| CN-112694447-A | Synthesis method of N-methyl triazine | 营口昌成新材料科技有限公司 | 2021-04-23 | — | — | CN | disclosed |
| CN-112694447-A | Synthesis method of N-methyl triazine | 营口昌成新材料科技有限公司 | 2021-04-23 | — | — | CN | disclosed |
| US-10441666-B2 | Tricarbocyanine-cyclodextrin(s) conjugates and use thereof | CYANAGEN S.R.L. (IT) | 2019-10-15 | — | — | US | disclosed |
| US-9853228-B2 | Metal complexes | MERCK PATENT GMBH (DE) | 2017-12-26 | — | — | US | disclosed |
| US-5186734-A | HERBICIDAL BISAZINYL COMPOUNDS | BAYER AKTIENGESELLSCHAFT (DE) | 1993-02-16 | — | — | US | disclosed |
| US-5151514-A | Triazine substituted herbicides | BAYER AKTIENGESELLSCHAFT (DE) | 1992-09-29 | — | — | US | disclosed |
| WO-1992014715-A1 | SULFONYL UREA DERIVATES, METHOD FOR PREPARING THEM AND USE THEREOF | BASF AKTIENGESELLSCHAFT (DE) | 1992-09-03 | — | — | WO | disclosed |
| US-5142060-A | Herbicidal substituted 4-sulphonylamino-2-azinyl-1,2,4-triazol-3-ones | BAYER AKTIENGESELLSCHAFT (DE) | 1992-08-25 | — | — | US | disclosed |
| EP-0477637-A1 | Bisazinylic compounds | BAYER AG (DE) | 1992-04-01 | — | — | EP | disclosed |
| US-5095113-A | Preparation of methyl-1,3-5-triazines | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1992-03-10 | — | — | US | disclosed |
| US-5089627-A | Chemical intermediates therefor | BAYER AKTIENGESELLSCHAFT (DE) | 1992-02-18 | — | — | US | disclosed |
| US-5085687-A | HERBICIDAL SUBSTITUTED 4-SULPHONYLAMINO-2-AZINYL-1,2,4-TRIAZOL-3-ONES | BAYER AKTIENGESELLSCHAFT (DE) | 1992-02-04 | — | — | US | disclosed |
| US-4988381-A | HERBICIDES, PLANT GROWTH REGULATORS | BAYER AKTIENGESELLSCHAFT (DE) | 1991-01-29 | — | — | US | disclosed |
| EP-0384244-A1 | Sulfonylimino-azinyl heteroazoles, method and intermediates for their preparation and their use as herbicides | BAYER AG (DE) | 1990-08-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10441666-B2 | Tricarbocyanine-cyclodextrin(s) conjugates and use thereof | KRTCAP2, DSC1, TBCD | CYP1A2 3832/4885GAA 244/4885ALDH1A1 2927/4885 |
| US-20230219983-A1 | TETRADENTATE DIAMINODIPHOSPHINE LIGAND AND TRANSITION METAL COMPLEX, AND METHOD FOR MANUFACTURING SAME AND APPLICATION FOR SAME | ADH4, ADH5, PF4 | CYP1A2 1363/4885GAA 3778/4885ALDH1A1 219/4885 |
| US-11639362-B2 | Tetradentate diaminodiphosphine ligand and transition metal complex, and method for manufacturing same and application for same | ADH4, ADH5, PF4 | CYP1A2 1363/4885GAA 3778/4885ALDH1A1 219/4885 |
| US-20220047724-A1 | NOVEL TRICARBOCYANINE-CYCLODEXTRIN(S) CONJUGATES AND USE THEREOF | KRTCAP2, DSC1, TBCD | CYP1A2 3694/4885GAA 339/4885ALDH1A1 2627/4885 |
| US-11840545-B1 | Spirooxindole-copper complex as novel efficient anticorrosion agent for C-steel | SOD1, CUL1, CTRC | CYP1A2 2820/4885GAA 2449/4885ALDH1A1 926/4885 |
| US-11179481-B2 | Tricarbocyanine-cyclodextrin(s) conjugates and use thereof | KRTCAP2, DSC1, TBCD | CYP1A2 3832/4885GAA 244/4885ALDH1A1 2927/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.